CircNR3C1 interacts with BRD4, disrupting the BRD4/C-myc complex that promotes BC progression, and in vivo studies showed that ectopic expression of C-myc can partially reverse the tumor-suppressive effects of circNR3C1 [10]. Here, MYC is linked to breast cancer.